PR Newswire
15 Jun 2022, 23 GMT+10
The company obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by the Netherlands CIBG of Ministry of Health, Welfare and Sport.
GUANGZHOU, China, June 15, 2022 /PRNewswire/ -- PulmoSeekTM Lung Cancer Early Detection Assay, the non-invasive blood-based cfDNA methylation detection product developed by AnchorDx for the early diagnosis of lung cancer, recently completed the procedure for EU IVDD CE Marking, and obtained IVD reagents licensing signed and issued by the CIBG of Ministry of Health, Welfare and Sport in the Netherlands. The license number is NL-CA002-2022-71591.
PulmoSeekTM is applicable for the benign and malignant diagnosis of people with 5-30mm pulmonary nodules. In the earlier stage of prospective clinical studies at 14 centers, the product's excellent performance was well verified in the following:
According to GLOBOCAN 2020 data released by the International Agency for Research on Cancer (IARC), lung cancer is the leading cause of cancer deaths (18%) with more than 2.2 million new cases and 1.8 million deaths annually worldwide. As a screening technology for lung cancer, LDCT has been widely recognized by domestic and international clinical guidelines, but the precise management of patients with pulmonary nodules after LDCT screening has also become an urgent clinical problem to be solved.
PulmoSeekTM Lung Cancer Early Detection Assay can achieve early diagnosis and treatment of lung cancer through accurate diagnosis of patients with benign and malignant pulmonary nodules. Currently, several of AnchorDx's products have obtained relevant IVD-related qualifications from US FDA and European Medicines Agency (EMA). PulmoSeek's access permit for the EU market will further promote this innovative precision medical product to benefit more patients with pulmonary nodules around the world forthwith.
About AnchorDx
AnchorDx is a world-leading developer of cancer screening and early detection solutions based on methylation NGS technology. AnchorDx strives to revolutionize single/multi/pan-cancer early screening, detection technologies, and products. The current product pipeline encompasses more than 70% of all cancers.
CONTACT : PR@anchordx.com
SOURCE Guangzhou AnchorDx Co., LTD
Get a daily dose of Sydney Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Sydney Sun.
More InformationSYDNEY, NSW, Australia - Stocks in Asia traded sharply lower on Thursday, following on from major falls on Wall Street ...
BERLIN, Germany: A German Interior Ministry spokesperson has said that in a bid to relieve airports overwhelmed by staff shortages ...
PARIS, France: In a written statement made this week confirming a report from broadcaster RTL, France's energy ministry said the ...
NEW YORK, New York - Wall Street struggled to find its footing on Wednesday after Fed chief Jerome Powell vowed ...
WASHINGTON D.C.: Due to persistent shortages of agricultural chemicals that threaten yields, U.S. farmers have cut back on using common ...
WASHINGTON D.C.: Raytheon Technologies and Northrop Grumman have won U.S. contracts to develop missiles to intercept hypersonic weapons.The decision means ...
WATFORD, UK: Watford F.C. has cancelled a friendly match against the Qatar national team due to the Gulf country's human ...
ISTANBUL, Turkey: Turkish police detained dozens of people after local authorities banned Istanbul's annual Pride parade from going ahead this ...
PARIS, France: Amidst shortages and soaring prices caused by Russia's invasion of Ukraine and subsequent supply cuts, the heads of ...
WASHINGTON D.C.: In the latest in a series of sanctions aimed at further isolating Russia economically over its invasion of ...
MAGWAY, Myanmar - At least eight resistance fighters were killed on Wednesday when junta troops intercepted a truck they were ...
SHANGHAI, China: As Shanghai reports no new cases of Covid for the first time in two months, Shanghai's top communist ...